European Companies Search Engine
EU funding (€100,000): Role of the Alpha4 Integrin (CD49d) in Type-1 Diabetes Mellitus Prevention and Treatment Fts3 Sept 2007 Financial Transparency System
Overview
Text
Project
| Subject of Grant or Contract | Role of the alpha4 integrin (CD49d) in Type-1 Diabetes mellitus prevention and treatment |
| Responsible Department | RTD - Directorate-General for Research and Innovation |
| Programme Name | 1.1.1 - Seventh Research framework programme (including sixth Research framework programme) |
| Type of Contract* | Action Grant |
| Reference of the Legal Commitment (LC) | EMI.1130 |
| Management Type | Indirect management |
| Geographical Zone | - |
| Budget | BGUE |
| Action Location | - |
| Commitment Total Amount (EUR) (A+B) | 100,000.00 |
| Project end Date | 02/09/2011 |
| Commitment Contracted Amount (EUR) (A) | 100,000.00 |
| Budget Line Name | People |
| Funding Type | Grant |
| Additional/Reduced Amount (EUR) (B) | 0.00 |
| Year | 2007 |
| Reference (Budget) | SI2.476906.1 |
| Commitment Consumed Amount (EUR) | 100,000.00 |
| Budget Line Number | 08 11 01 |
| Project Start Date | 03/09/2007 |
| Expense Type | Operational |
Beneficiaries
| Coordinator | Yes |
| Address | SENCKENBERGANLAGE 31 |
| Beneficiary’s Contracted Amount (EUR) | 100,000.00 |
| Beneficiary’s Estimated Contracted Amount (EUR) | 100,000.00 |
| Postal Code | 60325 |
| Beneficiary Country | Germany |
| Beneficiary’s Estimated Consumed Amount (EUR) | 100,000.00 |
| VAT Number of Beneficiary | DE114110511 |
| Beneficiary Group Code | LE04 |
| Not-for-Profit Organisation (Nfpo) | No |
| Beneficiary Type | Public Bodies |
| Name of Beneficiary | JOHANN WOLFGANG GOETHE-UNIVERSITATFRANKFURT AM MAIN* |
| NUTS2 | Darmstadt |
| City | FRANKFURT AM MAIN |
| Non-Governmental Organisation (NGO) | No |
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Johann Wolfgang Goethe-Universität, Frankfurt am Main, Frankfurt a. Main, Germany.
The visualizations for "JOHANN WOLFGANG GOETHE-UNIVERSITATFRANKFURT AM MAIN - EU funding (€100,000): Role of the Alpha4 Integrin (CD49d) in Type-1 Diabetes Mellitus Prevention and Treatment"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
